In a recent study published in The Lancet EBioMedicine, a team of scientists used Mendelian Randomization analyses to explore whether antidiabetic medications could potentially be used as ...

SGLT2 inhibitor use was associated with a significantly lower risk for androgen deprivation therapy (ADT) failure and next-generation hormonal agent failure in men with prostate cancer. SGLT2 ...

Nearly 2.2 million patients were prescribed a GLP-1 RA between January 2019 and December 2025, according to the study.

Compared with insulin alone, oral antidiabetic drugs alone or in addition to insulin were associated with reduced fracture risks among patients with type 2 diabetes. Oral antidiabetic drugs (OADs) are ...

Analysis of more than 1.5 million records of patients with type 2 diabetes casts light on the risk of dementia and Alzheimer’s disease and potential benefits associated with antidiabetic treatment, ...

Roasted coffee may do more than wake you up—it could help control blood sugar. Researchers discovered several new coffee ...

In a recent study published in the EClinicalMedicine, a group of researchers evaluated the 12-month neurological and psychiatric outcomes of semaglutide use in patients with type 2 diabetes mellitus ...

A study compared the association of semaglutide vs other antidiabetic medications and other GLP-1RAs, including liraglutide and dulaglutide, with opioid overdose risk in patients with comorbid type 2 ...

Compared to some antidiabetic medications, a 5:2 intermittent diet provides better blood sugar control and weight loss in newly diagnosed type 2 diabetics, a new study found. It may be a viable ...

Researchers have analyzed how an antidiabetic treatment could help control the growth of tumors, potentially paving the way for the design of better cancer treatments. Flinders University researchers ...